Authors/Disclosures
|
Olivia S. Kim Mcmanus, MD
(University of California San Diego Neurosciences/Rady Children's Institute for Genomic Medicine)
|
Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina . Dr. Kim Mcmanus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Kim Mcmanus has received research support from California Institute for Regenerative Medicine. The institution of Dr. Kim Mcmanus has received research support from National Institutes of Health/NCATS. |
|
Taeun Chang, MD
(Children's National Medical Center)
|
No disclosure on file |
|
Kavita M. Grover, MD, FAAN
|
Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. |
|
Tammy Tsuchida, MD, PhD
(Children's National Hospital)
|
The institution of Dr. Tsuchida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon Pharmaceuticals Inc. The institution of Dr. Tsuchida has received research support from Xenon Pharmaceuticals Inc. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |